心血管康复医学杂志2024,Vol.33Issue(2) :131-136.DOI:10.3969/j.issn.1008-0074.2024.02.03

不同临床特点CHF患者甲状腺激素水平及其与心功能指标的相关性研究

Thyroid hormone levels among CHF patients with different clinical characteristics and their correlation with heart function indexes

沈欢欢 刘蕾 许左隽 孙婷
心血管康复医学杂志2024,Vol.33Issue(2) :131-136.DOI:10.3969/j.issn.1008-0074.2024.02.03

不同临床特点CHF患者甲状腺激素水平及其与心功能指标的相关性研究

Thyroid hormone levels among CHF patients with different clinical characteristics and their correlation with heart function indexes

沈欢欢 1刘蕾 2许左隽 2孙婷2
扫码查看

作者信息

  • 1. 上海市虹口区江湾镇街道社区卫生服务中心全科,上海 200434;上海交通大学医学院附属第九人民医院心内科
  • 2. 上海市虹口区江湾镇街道社区卫生服务中心全科,上海 200434
  • 折叠

摘要

目的:研究不同临床特点慢性心力衰竭(CHF)患者甲状腺激素水平及其影响因素,以及与心功能指标的相关性.方法:收集2015年9月至2017年9月我院心内科住院的CHF患者295例,根据不同临床特点进行分组,对比分析各组甲状腺激素水平,以及与心功能指标的相关性,分析CHF合并低总三碘甲状腺原氨酸(TT3)的影响因素.结果:与NY-HA Ⅱ-Ⅲ级组比较,Ⅳ级组 FT3[(2.68±0.36)mmol/L 比(2.47±0.41)mmol/L]、TT3[(0.84±0.24)mmol/L 比(0.68± 0.21)mmol/L]水平显著降低;与病程≤2 年组比较,病程>2 年组 TT3[(0.80±0.25)mmol/L 比(0.73±0.24)mmol/L]、TT4[(8.77±1.84)mmol/L 比(8.37±1.52)mmol/L]水平显著降低;与 GFR≥60ml/min 组比较,GFR<60ml/min 组FT3[(2.67±0.38)mmol/L 比(2.47±0.40)mmol/L]、TT3[(0.83±0.23)mmol/L 比(0.69±0.24)mmol/L]水平显著降低,P<0.05或<0.01.低TT3组舒张末室间隔厚度(IVSTd)增厚比例显著高于正常TT3组(55.4%比43.0%),P=0.044.Pearson 相关分析显示,TT4 与 LVEF,FT4 与 LAD 呈显著正相关(r=0.126,0.145,P=0.030,0.013),TT3 与LVPWT呈显著负相关(r=-0.119,P=0.041).多因素Logistic回归分析显示,年龄、NYHA分级和I VSTd均是心力衰竭合并低TT3的独立危险因素,P<0.05或<0.01.结论:慢性心力衰竭患者心衰病程延长、心衰加重、伴随肾功能恶化等更容易出现甲状腺激素水平的降低.

Abstract

Objective:To study thyroid hormone levels among patients with chronic heart failure(CHF)and different clini-cal characteristics and its influencing factors,as well as their correlation with heart function indexes.Methods:A total of 295 CHF patients hospitalized in our Department of Cardiology from Sep 2015 to Sep 2017 were collected,grouped according to different clinical characteristics.Thyroid hormone levels were compared among all groups.Their correlation with cardiac function indexes,influencing factors of CHF complicated low TT3 were analyzed.Results:Compared with NYHA class Ⅱ-Ⅲ group,there were significant reductions in levels of FT3[(2.68±0.36)mmol/L vs.(2.47±0.41)mmol/L]and TT3[(0.84±0.24)mmol/L vs.(0.68±0.21)mmol/L]in class Ⅳ group;compared with course ≤2 years group,there were significant reductions in levels of TT3[(0.80±0.25)mmol/L vs.(0.73±0.24)mmol/L]and TT4[(8.77±1.84)mmol/L vs.(8.37±1.52)mmol/L]in course>2 years group;compared with GFR≥60ml/min group,there were significant re-ductions in levels of FT3[(2.67±0.38)mmol/L vs.(2.47±0.40)mmol/L]and TT3[(0.83±0.23)mmol/L vs.(0.69± 0.24)mmol/L]in GFR<60ml/min group,P<0.05 or<0.01.Percentage of increased end-diastolic interventricular sep-tal thickness(IVSTd)in low TT3 group was significantly higher than that of normal TT3 group(55.4%vs.43.0%),P=0.044.Pearson correlation analysis indicated that TT4,FT4 was significant positively correlated with LVEF and LAD re-spectively(r=0.126,0.145,P=0.030,0.013),and TT3 was significant inversely correlated with LVPWT(r=-0.119,P=0.041).Multifactor Logistic regression analysis indicated that age,NYHA class and IVSTd were independent risk factors for CHF complicated low TT3,P<0.05 or<0.01.Conclusion:Patients with chronic heart failure,when ac-companied with prolonged disease course,aggravated heart failure,and worsening of kidney function etc.,are more likely to occur reductions of thyroid hormone levels.

关键词

心力衰竭/甲状腺激素类/三碘甲状腺原氨酸/心室功能,左

Key words

Heart failure/Thyroid hormones/Triiodothyronine/Ventricular function,left

引用本文复制引用

基金项目

上海市"医苑新星"青年医学人才培育资助计划(2020)()

出版年

2024
心血管康复医学杂志
福建省康复医学会 中国康复医学会

心血管康复医学杂志

CSTPCD
影响因子:1.157
ISSN:1008-0074
参考文献量12
段落导航相关论文